NO954389L - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents

Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Info

Publication number
NO954389L
NO954389L NO954389A NO954389A NO954389L NO 954389 L NO954389 L NO 954389L NO 954389 A NO954389 A NO 954389A NO 954389 A NO954389 A NO 954389A NO 954389 L NO954389 L NO 954389L
Authority
NO
Norway
Prior art keywords
salt
squalene synthetase
synthetase inhibitor
phosphonosulfonate
inhibitor salts
Prior art date
Application number
NO954389A
Other languages
English (en)
Norwegian (no)
Other versions
NO954389D0 (no
Inventor
Yadagiri Pendri
Chung Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO954389D0 publication Critical patent/NO954389D0/no
Publication of NO954389L publication Critical patent/NO954389L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO954389A 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte NO954389L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
NO954389D0 NO954389D0 (no) 1995-11-02
NO954389L true NO954389L (no) 1996-05-06

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954389A NO954389L (no) 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Country Status (14)

Country Link
EP (1) EP0710665A1 (cs)
JP (1) JPH08208672A (cs)
KR (1) KR960017680A (cs)
CN (1) CN1130188A (cs)
AU (1) AU3458795A (cs)
CA (1) CA2159850A1 (cs)
CZ (1) CZ279595A3 (cs)
FI (1) FI955256A7 (cs)
HU (1) HUT73140A (cs)
IL (1) IL115537A0 (cs)
NO (1) NO954389L (cs)
PL (1) PL311218A1 (cs)
TW (1) TW318852B (cs)
ZA (1) ZA959326B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
EP1332763A4 (en) * 2000-11-09 2007-03-14 Takeda Pharmaceutical HIGH DENSITY AGENT Raising LIPOPROTEIN-CHOLESTEROL RATE
JP2008536933A (ja) 2005-04-18 2008-09-11 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 細菌感染のための抗菌療法
KR101385868B1 (ko) * 2006-05-12 2014-04-17 유니버시티 오브 일리노이즈 앳 어바나-샴페인 세균 감염에 대한 항균 요법
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
CN1130188A (zh) 1996-09-04
TW318852B (cs) 1997-11-01
FI955256L (fi) 1996-05-04
IL115537A0 (en) 1996-01-19
AU3458795A (en) 1996-05-09
CA2159850A1 (en) 1996-05-04
KR960017680A (ko) 1996-06-17
HU9503136D0 (en) 1995-12-28
JPH08208672A (ja) 1996-08-13
PL311218A1 (en) 1996-05-13
ZA959326B (en) 1997-05-05
HUT73140A (en) 1996-06-28
NO954389D0 (no) 1995-11-02
FI955256A0 (fi) 1995-11-02
EP0710665A1 (en) 1996-05-08
CZ279595A3 (en) 1996-08-14
FI955256A7 (fi) 1996-05-04

Similar Documents

Publication Publication Date Title
WO1996040745A3 (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
HU9601412D0 (en) Isoxazoline compounds as antiinflammatory agents
HU9401571D0 (en) Saccharin derivative proteolytic enzyme inhibitors
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
BG102738A (en) Inhibitors of farnesyl-protein transferase
DK327689A (da) Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK0526488T3 (da) Benzylphosphonsyre-tyrosinkinaseinhibitorer
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
BR0010220A (pt) Compostos de pirimidinona
CA2144372A1 (en) Composition for water treatment
FI971974A0 (fi) Tienopyridiini- tai tienopyrimidiinijohdannaiset ja niiden käyttö
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
FI953157A0 (fi) Ympärist¦lietteen käsittelymenetelmä
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
NO954389L (no) Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte
BR0002297A (pt) Aditivo de gênero alimentìcio que contém ácido d-pantotênico e/ou seus sais e um processo para a sua preparação
MA23790A1 (fr) Procede pour desactiver ou detruire des microorganismes
MX9803645A (es) Microparticulas minerales sinteticas, auxiliar de retencion, sistemas de tratamiento de agua y metodos que usan dichas particulas.
DK0712278T3 (da) N-pyridyltoluidinholdigt svampedræbende, vanddispergerbart granulat
WO2000023060A8 (en) Method of treating immunological disorders mediated by t-lymphocytes
MY112593A (en) A storage stable water solution for infusion containing a thrombin inhibitor
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
DK0498316T3 (da) Mikrobiologisk fremgangsmåde til fremstilling af 6-hydroxypicolinsyre
AU7063287A (en) A composition for inhibiting corrosion in industrial cooling waters and a method for improving the performance of corrosion inhibitors in same
AU5121199A (en) Processes for producing highly pure nicotinamide